S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
Free Trial
LON:VRCI

Verici Dx (VRCI) Share Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free VRCI Stock Alerts
GBX 8.25
+0.25 (+3.18%)
(As of 02:11 PM ET)
Compare
Today's Range
8.25
▼
8.50
50-Day Range
7.73
▼
11.79
52-Week Range
5.50
▼
19
Volume
13,946 shs
Average Volume
361,880 shs
Market Capitalization
£20.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitors
VRCI stock logo

About Verici Dx Stock (LON:VRCI)

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company also develops Protega, a peripheral blood-based test that aims to predict the risk of fibrosis and long-term graft failure. Verici Dx plc was incorporated in 2020 and is based in Penarth, the United Kingdom.

VRCI Stock Price History

VRCI Stock News Headlines

February 24, 2024 | morningstar.com
Verici Dx PLC Ordinary Shares VRCI
February 1, 2024 | morningstar.com
Verici Dx PLC Ordinary Shares
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
November 10, 2023 | finance.yahoo.com
Verici Dx plc (63V.F)
July 25, 2023 | finance.yahoo.com
Companies Like Verici Dx (LON:VRCI) Could Be Quite Risky
May 25, 2023 | finance.yahoo.com
DX - Dynex Capital, Inc.
February 16, 2023 | finance.yahoo.com
Cloud DX Announces Private Placements of up to an Aggregate of $5.5 Million with Lead Orders of $1.5 Million
February 15, 2023 | finance.yahoo.com
We're Keeping An Eye On Verici Dx's (LON:VRCI) Cash Burn Rate
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
January 18, 2023 | benzinga.com
Dynex Cap Stock (NYSE:DX), Quotes and News Summary
September 8, 2022 | finance.yahoo.com
We Think Verici Dx (LON:VRCI) Needs To Drive Business Growth Carefully
September 3, 2022 | uk.finance.yahoo.com
Verici Dx plc (VRCI.L)
June 14, 2022 | marketwatch.com
Verici Releases Data on Tuteva Blood Test; Shares Dive
May 5, 2022 | finance.yahoo.com
American Shared Hospital Services Announces First Quarter 2022 Earnings Conference Call
April 9, 2022 | lse.co.uk
Verici Dx Share Chat
March 26, 2022 | investing.com
Verici Dx Plc (VRCI)
See More Headlines
Receive VRCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:VRCI
CUSIP
N/A
CIK
N/A
Web
www.vericidx.com
Phone
44 207 9338780
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX (0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-11,210,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-92.28%
Return on Assets
-47.86%

Debt

Debt-to-Equity Ratio
9.28
Current Ratio
2.58
Quick Ratio
8.49

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 6.29 per share
Price / Cash Flow
1.31
Book Value
GBX 4 per share
Price / Book
2.06

Miscellaneous

Outstanding Shares
242,540,000
Free Float
N/A
Market Cap
£20.02 million
Optionable
Not Optionable
Beta
1.48
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Ms. Sara Barrington A.C.A. (Age 57)
    A.C.I.M., CEO & Executive Director
    Comp: $281.77k
  • Mr. David M. Anderson (Age 61)
    Chief Financial Officer
  • Mr. Salim Gulamabbas Hamir F.C.A.
    Company Secretary

Key Competitors

View All Competitors

VRCI Stock Analysis - Frequently Asked Questions

How have VRCI shares performed in 2024?

Verici Dx's stock was trading at GBX 9.75 at the beginning of 2024. Since then, VRCI shares have decreased by 15.3% and is now trading at GBX 8.25.
View the best growth stocks for 2024 here.

How do I buy shares of Verici Dx?

Shares of VRCI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:VRCI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company